Many clinical prediction models for predicting patient prognosis and disease-free survival have been proposed, mainly focusing on age at diagnosis; post-menopausal status; ER, HER-2, and ki-67 status; tumor size; lymph node involvement; metastasis; and therapeutic strategy [4–7]. The gene discussed is ERBB2; the disease is neoplasm.